Ejemplo: Heart Attack

Ensayos clínicos patrocinados por Bio-Path Holdings, Inc

Total 5 resultados

NCT04196257

Aún no reclutando

BP1001-A in Patients With Advanced or Recurrent Solid Tumors

Condiciones: Solid Tumor, Adult; Carcinoma, Ovarian Epithelial; Fallopian Tube Neoplasms; Endometrial Cancer; Peritoneal Cancer; Solid Tumor
NCT04072458

Reclutamiento

A Clinical Trial of BP1002 in Patients With Advanced Lymphoid Malignancies

Condiciones: Mantle Cell Lymphoma; Peripheral T-cell Lymphoma (PTCL); Cutaneous T-cell Lymphoma (CTCL); Chronic Lymphocytic Leukemia (CLL); Small Lymphocytic Lymphoma (SLL); Follicular Lymphoma; Marginal Zone Lymphoma; Hodgkin Lymphoma; Waldenstrom Macroglobulinemia; DLBCL
NCT02923986

Retirado

Clinical Trial of BP1001 (Liposomal Grb2 Antisense Oligonucleotide) in Combination With Dasatinib in Patients With Ph + CML Who Have Failed TKI, Ph+ AML, Ph+ MDS

Condiciones: Chronic Myelogenous Leukemia, Ph1-Positive; Acute Myeloid Leukemia; Myelodysplastic Syndrome
NCT02781883

Reclutamiento

Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML

Condiciones: Acute Myeloid Leukemia (AML)
NCT01159028

Completado

Clinical Trial of BP1001 (L-Grb-2 Antisense Oligonucleotide) in CML, AML, ALL & MDS

Condiciones: Recurrent Adult Acute Myeloid Leukemia; Acute Lymphoblastic Leukemia; Myelodysplastic Syndrome; Ph1 Positive CML